This provider's $5.3M in total Medicare payments ranks in the 82th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 631% from 2018 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 453% in 2022
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2018 | $570.00 | $227.18 | 2.51x | $342.82 | $354.1K | 2.2K | 2.1K |
| 2019 | $683.33 | $219.15 | 3.12x | $464.18 | $468.2K | 3.4K | 3.3K |
| 2020 | $109.66 | $87.98 | 1.25x | $21.68 | $314.2K | 5.0K | 3.9K |
| 2021 | $86.34 | $81.49 | 1.06x | $4.85 | $245.8K | 4.5K | 2.9K |
| 2022 | $43.35 | $34.76 | 1.25x | $8.59 | $1.4M | 31.6K | 4.9K |
| 2023 | $41.73 | $27.99 | 1.49x | $13.74 | $2.6M | 45.3K | 4.5K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 17.9K | $1.3M | $74.43 | 1.41x |
| 87502 | Detection test for multiple types influenza virus | 9.4K | $881.9K | $93.91 | 1.63x |
| 87634 | Detection test for respiratory syncytial virus | 9.4K | $644.3K | $68.83 | 1.59x |
| 87633 | Detection test for multiple types of respiratory virus | 1.3K | $602.7K | $474.93 | 2.63x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 17.3K | $424.8K | $24.54 | 1.11x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17.9K | $412.0K | $23.04 | 1.20x |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 4.8K | $240.2K | $50.28 | 1.10x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 1.1K | $158.7K | $139.78 | 1.50x |
| 87631 | Detection test for multiple types of respiratory virus | 954 | $135.8K | $142.39 | 1.66x |
| 87581 | Detection test for Mycoplasma pneumoniae (bacteria) | 2.6K | $98.2K | $37.58 | 1.92x |
| 87798 | Detection test for organism | 2.6K | $98.2K | $37.58 | 1.90x |
| 87486 | Detection test for Chlamydia pneumoniae | 2.6K | $98.0K | $37.58 | 1.92x |
| 87507 | Detection test for digestive tract pathogen | 203 | $88.3K | $434.73 | 1.50x |
| 0100U | Test for detection of respiratory disease-causing organism using amplified probe, 20 target organisms (adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus, human rhinovirus/enterovirus, influenza A, inc | 107 | $31.3K | $292.63 | 4.27x |
| 87150 | Identification of organisms by genetic analysis | 665 | $23.3K | $35.09 | 1.04x |
| 87541 | Detection test for legionella pneumophila (water borne bacteria) | 594 | $20.8K | $35.09 | 1.04x |
| 87498 | Detection test for enterovirus (intestinal virus) | 277 | $9.7K | $35.09 | 1.03x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 444 | $3.4K | $7.61 | 1.49x |
| 36415 | Insertion of needle into vein for collection of blood sample | 336 | $2.8K | $8.40 | 1.30x |
| 80053 | Blood test, comprehensive group of blood chemicals | 269 | $2.8K | $10.35 | 1.39x |
This provider submits charges 1.6 times higher than what Medicare actually pays.
A markup ratio of 1.6x means for every $100 Medicare pays, this provider initially charges $160. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data